Clin2
NCT07389018Possibly a fitNot yet recruiting

Wearable sensors for monitoring PSP-R

Progressive Supranuclear Palsy- Richardson Syndrome (PSP-R)

Part of Brain & nervous system clinical trials.

This study tests if ankle-worn sensors can track movement and symptoms in people with progressive supranuclear palsy (Richardson syndrome). It may help find better ways to measure how the disease progresses.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 or older
  • You can walk 10 meters without help
  • You have been diagnosed with possible or probable PSP-Richardson syndrome
  • You agree to wear sensors on your ankles and do simple tasks
  • You have a caregiver or someone who can help you

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07074119Not yet recruiting
Optimizing Parkinson's treatment with wearable sensors

This trial tests if using a wearable sensor can help doctors better adjust Parkinson's medications to reduce motor fluctuations (times when symptoms are not well controlled). It is for people with Parkinson's who have been on levodopa for at least 4 years and experience ups and downs in their movement control.

Paris, Île-de-France Region
NCT04753320Not yet recruiting
Remote monitoring for progressive supranuclear palsy and related disorders

This study tests a remote monitoring system to track symptoms of progressive supranuclear palsy (PSP) and similar movement disorders. It may tell you how your condition changes over time without needing frequent clinic visits.

Baltimore, Maryland
NCT07173803Recruiting· Phase 2
PSP clinical trial testing new treatments

This trial tests potential new treatments for progressive supranuclear palsy (PSP), a brain disorder affecting movement, balance, and thinking. It aims to see if these treatments are safe and slow the disease. You may be able to join if you have a specific type of PSP and are in fairly good health.

Palo Alto, California
NCT07264283Enrolling by invitation· Phase 2
Testing LM11A-31 for progressive supranuclear palsy

This trial tests a drug called LM11A-31 to see if it can help people with progressive supranuclear palsy (PSP), a rare brain condition. You may join if you have had symptoms for 5 years or less, can walk with minimal help, and have good thinking abilities.

San Francisco, California
NCT07240805Not yet recruiting
Digital health tools for PSP and Lewy body dementia

This study tests digital health tools (like sensors or apps) to track symptoms of progressive supranuclear palsy (PSP) or dementia with Lewy bodies (DLB) at home. It may help researchers understand how these conditions progress and improve care.

Lutherville, Maryland
NCT05874739Recruiting
Track movement with a wearable sensor for 12 months

This study uses a wearable sensor to track how well people move over a year. It may help researchers understand mobility and how different movement conditions affect walking and daily function.

Newcastle upon Tyne

Hear when a new Progressive Supranuclear Palsy- Richardson Syndrome (PSP-R) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.